How a Lack of Critical Thinking is Hindering Regulatory Compliance
By Calvin Kim
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, Regulatory Sourcebook, March 2022
Volume 2022 eBook
Issue 1
Pages: 34–39
Why critical thinking must be applied before technology to ensure regulatory compliance.
AdobeStock_231551918_ Andrii Zastrozhnov
Throughout a single project, contract development and manufacturing organizations (CDMOs) generate an abundance of essential data that require an array of computerized systems to manage. These systems provide many benefits, including reducing human error, making processes more efficient, and enhancing security. More importantly, these systems can be used to help implement technical controls for data integrity (DI).
The importance of ensuring DI, particularly when data are used in decision-making for the regulated good practice (GxP) processes, is highlighted by the consistent updating of regulations first mandated by FDA in the early 1960s. Since that time, FDA and other regulatory agencies have continued to publish guidance emphasizing the need to maintain DI controls.
Before any new technology implementation, CDMOs need to fully understand the system as well as establish its intended use and perform risk mitigation to ensure robust DI controls. However, understanding and implementing the requirements of regulations surrounding computerized systems continues to be a challenge to many CDMOs today. Technology is not the predominant challenge to achieving regulatory compliance, but the lack of critical thinking skills when designing a quality system.
Read this article in Pharmaceutical Technology's March 2022 Quality and Regulatory Sourcebook eBook.
About the author
Calvin Kim is the senior director, head of IT quality systems and validation, for Samsung Biologics.
Article details
Pharmaceutical Technology
eBook: Quality and Regulatory Sourcebook
March 2022
Pages: 34–39
Citation
When referring to this article, please cite it as C. Kim, "How a Lack of Critical Thinking is Hindering Regulatory Compliance," Pharmaceutical Technology's Quality and Regulatory Sourcebook eBook (March 2022).
Articles in this issue
Common FDA 483 Observations for Combination Products
Facilitating Biopharma Continuous Manufacturing
In-Use Testing of Cleanroom Garments
How a Lack of Critical Thinking is Hindering Regulatory Compliance
A Method Validation Framework for Combination Products
Contextualizing Computer Validation
Supply Chain Considerations for Ensuring Quality
DSCSA’s Next Big Hurdle
Remote Inspections - Lessons Learned
Recent Videos
Related Content
